BI Asset Management Fondsmaeglerselskab A/S
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1778131
KOBENHAVN, G7
Position in VRTX
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$22,117,572
+$17,345,505 QoQ
Shares Held
49,531
+370.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 20.425592053461468.ToString("F0")%
Shared 0.ToString("F0")%
None 79.57440794653853.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BI Asset Management Fondsmaeglerselskab A/S holds $81,144,167 across 10 Biotechnology names. VRTX ranks #1 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
49,531 | $22,117,572 | |
| 2 | TECH |
BIO-TECHNE Corp
|
316,510 | $16,540,812 | |
| 3 | INCY |
Incyte Corp
|
155,246 | $14,611,753 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
148,752 | $9,613,841 | |
| 5 | EXEL |
Exelixis, Inc.
|
152,320 | $6,533,004 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
81,878 | $5,578,348 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,239 | $2,502,580 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,697 | $1,884,966 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,117,572 | 49,531 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $4,772,067 | 10,526 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,152,167 | 10,602 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $6,089,000 | 13,677 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,685,968 | 11,728 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,572,466 | 16,321 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,219,745 | 19,824 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,893,995 | 59,511 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $28,637,029 | 68,508 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $23,640,309 | 58,100 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $21,528,583 | 61,910 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,030,812 | 51,237 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $17,731,509 | 56,278 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,452,572 | 50,047 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,417,862 | 46,342 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $15,146,212 | 53,750 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $18,018,934 | 69,046 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $17,321,389 | 78,877 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $14,387,854 | 79,320 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $11,240,267 | 55,747 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $13,133,647 | 61,118 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $12,825,462 | 54,267 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,467,203 | 23,766 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $5,228,192 | 18,009 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,399,383 | 5,881 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||